Upcoming PGRN events

Switch to Calendar View

• Research in Progress - G6PD Genotype and Phenotype in the Clinical Setting

  • When
    Fri, December 11, 2020
  •  
    8:00 AM - 9:00 AM (PST)
  • Location
    Zoom - Members Only

  "G6PD Genotype and Phenotype in the Clinical Setting"

  Mary Relling, PharmD, Endowed Chair
  
  and

  Sarah Morris, PharmD, Clinical Pharmacogenomics Specialist
  St. Jude Children’s Research Hospital
  

  Show details
• Research in Progress - Robert Plenge, MD, PhD

  • When
    Fri, January 08, 2021
  •  
    8:00 AM - 9:00 AM (PST)
  • Location
    Zoom - Members Only

  "Human Genetics and Drug Discovery"
  Robert Plenge, MD, PhD
  Sr. Vice President - Research & Early Development
  Bristol Myers Squibb

  Show details
• Early Career RIPS - Genetics of Statin-Induced Toxicities in ODYSSEY OUTCOMES Trial Population

  • When
    Fri, January 22, 2021
  •  
    11:00 AM - 12:00 PM (EST)
  • Location
    Zoom - Members Only

  "Genetics of Statin-Induced Toxicities in ODYSSEY OUTCOMES Trial Population"
  PGRN President's 2020 Poster Award Winner
  

  
  William (Billy) A. Murphy, PharmD
  2^nd Year PhD Student
  UNC ESHELMAN SCHOOL OF PHARMACY
  Division of Pharmacotherapy and Experimental Therapeutics
  Chapel Hill, NC
  

  Show details
• Polygenic Risk Scores: Current Status and Future Utility

  • When
    Wed, February 17, 2021
  •  
    (EST)
  • Location
    Virtual

  
  The UK Pharmacogenetics & Stratified Medicine Network is pleased to present our first Virtual Workshop – “Polygenic Risk Scores: Current Status and Future Utility”. The event will be held online and hosted by Professor Sir Munir Pirmohamed.

  The first session will include talks on genetic profiling for prediction of Alzheimer’s disease, the impact of PRS on insurance, and the clinical utility of PRS.

  The afternoon session will see participants split into breakout groups to discuss:

  1. How can we further develop the utility of PRS?

  2. What will be the challenges and opportunities of implementing PRS into clinical practice?

  3. Ethical issues associated with the use of PRS. 

  Following these discussions, rapporteurs from each group will present their conclusions.
  
  For more information
  

  Show details